Furthermore, intracellular NF-kB activity in tumor cells is upregulated by both TRAIL death receptors (TRAIL-R1 and TRAIL-R2) [34,44] as well as TRAIL decoy receptor TRAIL-R4 [45] upon ligand binding. Here, TNFRSF10D is linked to neoplasm.